CSIMarket


Supernus Pharmaceuticals inc   (SUPN)
Other Ticker:  
 

Supernus Pharmaceuticals inc

SUPN's Fundamental analysis








Supernus Pharmaceuticals Inc 's sales fell by -14.15 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1173

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Supernus Pharmaceuticals Inc 's net profit deacreased by -99.51 % in I. Quarter 2024 year on year, to $0 millions.

More on SUPN's Growth


Supernus Pharmaceuticals Inc
realized net loss in trailing twelve months.

Supernus Pharmaceuticals Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.


More on SUPN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 611,303
 Net Income/Employee (TTM) $ 276
 Receivable Turnover (TTM) 4.12
 Tangible Book Value (Per Share $) 4.18

Supernus Pharmaceuticals Inc
realized net loss in trailing twelve months.

Supernus Pharmaceuticals Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.31.

Supernus Pharmaceuticals Inc Price to Book Ratio is at 1.65 lower than Indusry Avg. of 74.55. and higher than S&P 500 Avg. of 0.01

More on SUPN's Valuation

  Market Capitalization (Millions $) 1,530
  Shares Outstanding (Millions) 56
  Employees 960
  Revenues (TTM) (Millions $) 587
  Net Income (TTM) (Millions $) 0
  Cash Flow (TTM) (Millions $) -10
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 611,303
  Net Income/Employee(TTM) $ 276
  Receivable Turnover Ratio (TTM) 4.12
  Tangible Book Value (Per Share $) 4.18

  Market Capitalization (Millions $) 1,530
  Shares Outstanding (Millions) 56
  Employees 960
  Revenues (TTM) (Millions $) 587
  Net Income (TTM) (Millions $) 0
  Cash Flow (TTM) (Millions $) -10
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 3.69
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.89
  Asset Turnover Ratio (TTM) 0.41
  Inventory Turnover Ratio (TTM) 0.95





Supernus Pharmaceuticals Inc net profit margin of 0.09 % is currently ranking no. 40 in Major Pharmaceutical Preparations industry, ranking no. 131 in Healthcare sector and number 1803 in S&P 500.

More on SUPN's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com